Matthew Riddle - Articles and news items


Sanofi announces positive Phase 3 results for investigational new insulin U300

Industry news, News / 22 June 2013 / Sanofi

Topline results of EDITION II consistent with EDITION I findings…

New data from ORIGIN

Industry news, News / 5 October 2012 / Sanofi

New data from ORIGIN shows Lantus® use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...